Determinants of plasma brain natriuretic peptide levels in untreated hypertensive patients

Journal of Echocardiography

Volumn 9, Issue 3, 2011, Pages 103-108

  Goda, Akiko ^a   Nakao, Shinji ^a   Tsujino, Takeshi ^a   Yuba, Masao ^a   Otsuka, Misato ^a   Matsumoto, Mika ^a   Yoshida, Chikako ^a   Naito, Yoshiro ^a   Lee Kawabata, Masaaki ^a   Ohyanagi, Mitsumasa ^a   Masuyama, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

BNP; Echocardiography; Hypertension; Hypertrophy; LV diastolic function

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 80052364711     PISSN: 13490222     EISSN: 1880344X     Source Type: Journal    
DOI: 10.1007/s12574-011-0086-9     Document Type: Article

References (15)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 31: 1561-6.
2. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens. 2001; 19: 921-30.
3. Oishi Y, Mizuguchi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. Echocardiographic features of patients with congestive heart failure and preserved left ventricular pump function: a retrospective study in a selected common disease cohort. J Echocardiogr. 2008; 6: 9-14.
4. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997; 350: 1349-53.
5. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000; 355: 1126-30.
6. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992; 92: 29-34.
7. Suzuki M, Hamada M, Yamamoto K, Kazatani Y, Hiwada K. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events. Hypertens Res. 2002; 25: 669-76.
8. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58: 1072-83.
9. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens. 1995; 13: 155-60.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-63.
11. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992; 19: 1550-8.
12. Teicholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determination: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976; 37: 7-12.
13. Wallerson DC, Ganau A, Roman MJ, Devereux RB. Measurement of cardiac output by M-mode and two-dimensional echocardiography: application to patients with hypertension. Eur Heart J. 1990; 11(Suppl I): 67-78.
14. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension. 1996; 28: 22-30.
15. Nakao S, Goda A, Yuba M, Otsuka M, Matsumoto M, Yoshida C, et al. Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure. Circ J. 2000; 71: 12-7.